U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Hamartoma

MedGen UID:
6713
Concept ID:
C0018552
Neoplastic Process
Synonym: Hamartomas
SNOMED CT: Hamartoma (400006008); Hamartoma (51398009)
 
HPO: HP:0010566
Monarch Initiative: MONDO:0006499

Definition

A disordered proliferation of mature tissues that is native to the site of origin, e.g., exostoses, nevi and soft tissue hamartomas. Although most hamartomas are benign, some histologic subtypes, e.g., neuromuscular hamartoma, may proliferate aggressively such as mesenchymal cystic hamartoma, Sclerosing epithelial hamartoma, Sclerosing metanephric hamartoma. [from HPO]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVHamartoma

Conditions with this feature

Progressive myositis ossificans
MedGen UID:
4698
Concept ID:
C0016037
Disease or Syndrome
Fibrodysplasia ossificans progressiva (FOP) is characterized by congenital bilateral hallux valgus malformations and early-onset heterotopic ossification, which may be spontaneous or precipitated by trauma including intramuscular vaccinations. Painful, recurrent soft-tissue swellings (flare-ups) may precede localized heterotopic ossification. Heterotopic ossification can occur at any location, but typically affects regions in close proximity to the axial skeleton in the early/mild stages, before progressing to the appendicular skeleton. This can lead to restriction of movement as a result of ossification impacting joint mobility. Problems with swallowing and speaking can occur with ossification affecting the jaw, head, and neck, and restriction of the airway and breathing may lead to thoracic insufficiency syndrome.
Branchiooculofacial syndrome
MedGen UID:
91261
Concept ID:
C0376524
Disease or Syndrome
The branchiooculofacial syndrome (BOFS) is characterized by: branchial (cervical or infra- or supra-auricular) skin defects that range from barely perceptible thin skin or hair patch to erythematous "hemangiomatous" lesions to large weeping erosions; ocular anomalies that can include microphthalmia, anophthalmia, coloboma, and nasolacrimal duct stenosis/atresia; and facial anomalies that can include ocular hypertelorism or telecanthus, broad nasal tip, upslanted palpebral fissures, cleft lip or prominent philtral pillars that give the appearance of a repaired cleft lip (formerly called "pseudocleft lip") with or without cleft palate, upper lip pits, and lower facial weakness (asymmetric crying face or partial 7th cranial nerve weakness). Malformed and prominent pinnae and hearing loss from inner ear and/or petrous bone anomalies are common. Intellect is usually normal.
Orofaciodigital syndrome VIII
MedGen UID:
208667
Concept ID:
C0796101
Disease or Syndrome
Abnormalities of the digits can affect both the fingers and the toes in people with oral-facial-digital syndrome. These abnormalities include fusion of certain fingers or toes (syndactyly), digits that are shorter than usual (brachydactyly), or digits that are unusually curved (clinodactyly). The presence of extra digits (polydactyly) is also seen in most forms of oral-facial-digital syndrome.\n\nOther features occur in only one or a few types of oral-facial digital syndrome. These features help distinguish the different forms of the disorder. For example, the most common form of oral-facial-digital syndrome, type I, is associated with polycystic kidney disease. This kidney disease is characterized by the growth of fluid-filled sacs (cysts) that interfere with the kidneys' ability to filter waste products from the blood. Other forms of oral-facial-digital syndrome are characterized by neurological problems, particular changes in the structure of the brain, bone abnormalities, vision loss, and heart defects.\n\nDistinctive facial features often associated with oral-facial-digital syndrome include a split in the lip (a cleft lip); a wide nose with a broad, flat nasal bridge; and widely spaced eyes (hypertelorism).\n\nAbnormalities of the oral cavity that occur in many types of oral-facial-digital syndrome include a split (cleft) in the tongue, a tongue with an unusual lobed shape, and the growth of noncancerous tumors or nodules on the tongue. Affected individuals may also have extra, missing, or defective teeth. Another common feature is an opening in the roof of the mouth (a cleft palate). Some people with oral-facial-digital syndrome have bands of extra tissue (called hyperplastic frenula) that abnormally attach the lip to the gums.\n\nThe signs and symptoms of oral-facial-digital syndrome vary widely. However, most forms of this disorder involve problems with development of the oral cavity, facial features, and digits. Most forms are also associated with brain abnormalities and some degree of intellectual disability.\n\nResearchers have identified at least 13 potential forms of oral-facial-digital syndrome. The different types are classified by their patterns of signs and symptoms. However, the features of the various types overlap significantly, and some types are not well defined. The classification system for oral-facial-digital syndrome continues to evolve as researchers find more affected individuals and learn more about this disorder.\n\nOral-facial-digital syndrome is actually a group of related conditions that affect the development of the oral cavity (the mouth and teeth), facial features, and digits (fingers and toes).
Orofaciodigital syndrome IX
MedGen UID:
162908
Concept ID:
C0796102
Disease or Syndrome
Syndrome with characteristics of highly arched palate with bifid tongue and bilateral supernumerary lower canines, hamartomatous tongue, multiple frenula, hypertelorism, telecanthus, strabismus, broad and/or bifid nasal tip, short stature, bifid hallux, forked metatarsal, poly and syndactyly, mild intellectual deficit and specific retinal abnormalities (bilateral optic disc coloboma and retinal dysplasia with partial detachment). Less than ten cases have been described in the literature. The causative gene has not yet been identified.
Hyperparathyroidism 2 with jaw tumors
MedGen UID:
310065
Concept ID:
C1704981
Neoplastic Process
The spectrum of CDC73-related disorders includes the following phenotypes: Hyperparathyroidism-jaw tumor (HPT-JT) syndrome. Primary hyperparathyroidism, the main finding of HPT-JT syndrome, occurs in up to 95% of affected individuals; onset is typically in late adolescence or early adulthood. HPT-JT-associated primary hyperparathyroidism is usually caused by a single parathyroid adenoma. In approximately 10%-15% of individuals, primary hyperparathyroidism is caused by parathyroid carcinoma. Ossifying fibromas of the mandible or maxilla, also known as cementifying fibromas and cemento-ossifying fibromas, occur in 30%-40% of individuals with HPT-JT syndrome. Although benign, these tumors can be locally aggressive and may continue to enlarge if not treated. Approximately 20% of individuals with HPT-JT syndrome have kidney lesions, most commonly cysts; renal hamartomas and (more rarely) Wilms tumor have also been reported. Benign and malignant uterine tumors appear to be common in women with HPT-JT syndrome. Parathyroid carcinoma. Most parathyroid carcinomas are functional, resulting in hyperparathyroidism and a high serum calcium level; however, nonfunctioning parathyroid carcinomas are also rarely described in individuals with a CDC73-related disorder. A germline CDC73 pathogenic variant has been identified in 20%-29% of individuals with apparently sporadic parathyroid carcinoma. Familial isolated hyperparathyroidism (FIHP). FIHP is characterized by primary hyperparathyroidism without other associated syndromic features. Individuals with CDC73-related FIHP tend to have a more severe clinical presentation and younger age of onset than individuals with FIHP in whom a CDC73 pathogenic variant has not been identified.
Lip, hamartomatous
MedGen UID:
331965
Concept ID:
C1835395
Disease or Syndrome
Hamartoma, Precalcaneal congenital fibrolipomatous
MedGen UID:
342846
Concept ID:
C1853298
Disease or Syndrome
Generalized basaloid follicular hamartoma syndrome
MedGen UID:
343009
Concept ID:
C1853919
Disease or Syndrome
Generalized basaloid follicular hamartoma syndrome is a rare, genetic skin disease characterized by multiple milium-like, comedone-like lesions and skin-colored to hyperpigmented, 1 to 2 mm-sized papules, associated with hypotrichosis and palmar/plantar pits. Lesions are usually first noticed on cheeks or neck and gradually increase in size and number to involve the scalp, face, ears, shoulders, chest, axillas, and upper arms. In severe cases, lower back, lower arms, and back of the legs can be involved. Mild hypohidrosis has also been reported.
Nasopalpebral lipoma-coloboma syndrome
MedGen UID:
358378
Concept ID:
C1868660
Disease or Syndrome
Nasopalpebral lipoma-coloboma syndrome (NPLCS) is an autosomal dominant condition characterized by upper eyelid and nasopalpebral lipomas, colobomas of upper and lower eyelids, telecanthus, and maxillary hypoplasia (summary by Suresh et al., 2011).
Cowden syndrome 4
MedGen UID:
767431
Concept ID:
C3554517
Disease or Syndrome
The features of Cowden syndrome overlap with those of another disorder called Bannayan-Riley-Ruvalcaba syndrome. People with Bannayan-Riley-Ruvalcaba syndrome also develop hamartomas and other noncancerous tumors.  Some people with Cowden syndrome have relatives diagnosed with Bannayan-Riley-Ruvalcaba syndrome, and other affected individuals have the characteristic features of both conditions. Based on these similarities, researchers have proposed that Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome represent a spectrum of overlapping features known as PTEN hamartoma tumor syndrome (named for the genetic cause of the conditions) instead of two distinct conditions.\n\n\n\nSome people do not meet the strict criteria for a clinical diagnosis of Cowden syndrome, but they have some of the characteristic features of the condition, particularly the cancers. These individuals are often described as having Cowden-like syndrome. Both Cowden syndrome and Cowden-like syndrome are caused by mutations in the same genes.\n\nCowden syndrome is associated with an increased risk of developing several types of cancer, particularly cancers of the breast, a gland in the lower neck called the thyroid, and the lining of the uterus (the endometrium). Other cancers that have been identified in people with Cowden syndrome include kidney cancer, colorectal cancer, and an agressive form of skin cancer called melanoma. Compared with the general population, people with Cowden syndrome develop these cancers at younger ages, often beginning in their thirties or forties. People with Cowden syndrome are also more likely to develop more than one cancer during their lifetimes compared to the general population. Other diseases of the breast, thyroid, and endometrium are also common in Cowden syndrome. Additional signs and symptoms can include an enlarged head (macrocephaly) and a rare, noncancerous brain tumor called Lhermitte-Duclos disease. A small percentage of affected individuals have delayed development, intellectual disability, or autism spectrum disorder, which can affect communication and social interaction.\n\nAlmost everyone with Cowden syndrome develops hamartomas. These growths are most commonly found on the skin and mucous membranes (such as the lining of the mouth and nose), but they can also occur in the intestine and other parts of the body. The growth of hamartomas on the skin and mucous membranes typically becomes apparent by a person's late twenties.\n\nCowden syndrome is a genetic disorder characterized by multiple noncancerous, tumor-like growths called hamartomas and an increased risk of developing certain cancers.
Short-rib thoracic dysplasia 15 with polydactyly
MedGen UID:
934691
Concept ID:
C4310724
Disease or Syndrome
Short-rib thoracic dysplasia (SRTD) with or without polydactyly refers to a group of autosomal recessive skeletal ciliopathies that are characterized by a constricted thoracic cage, short ribs, shortened tubular bones, and a 'trident' appearance of the acetabular roof. SRTD encompasses Ellis-van Creveld syndrome (EVC) and the disorders previously designated as Jeune syndrome or asphyxiating thoracic dystrophy (ATD), short rib-polydactyly syndrome (SRPS), and Mainzer-Saldino syndrome (MZSDS). Polydactyly is variably present, and there is phenotypic overlap in the various forms of SRTDs, which differ by visceral malformation and metaphyseal appearance. Nonskeletal involvement can include cleft lip/palate as well as anomalies of major organs such as the brain, eye, heart, kidneys, liver, pancreas, intestines, and genitalia. Some forms of SRTD are lethal in the neonatal period due to respiratory insufficiency secondary to a severely restricted thoracic cage, whereas others are compatible with life (summary by Huber and Cormier-Daire, 2012 and Schmidts et al., 2013). There is phenotypic overlap with the cranioectodermal dysplasias (Sensenbrenner syndrome; see CED1, 218330). SRTD15 is characterized by narrow thorax, oral and cardiovascular anomalies, short long bones, and postaxial polydactyly, in addition to other congenital anomalies. Considerable variability in features and in severity has been reported, with some affected individuals succumbing shortly after birth and others living to adulthood, even within the same family. For a discussion of genetic heterogeneity of short-rib thoracic dysplasia with or without polydactyly, see SRTD1 (208500).
Congenital smooth muscle hamartoma, with or without hemihypertrophy
MedGen UID:
1847218
Concept ID:
C5882676
Congenital Abnormality
Congenital smooth muscle hamartoma (CSMH) is a benign skin lesion that presents as an indurated, slightly pigmented or flesh-colored plaque with perifollicular papules or coarse hair. Histopathologically, there is excessive proliferation of ectopic smooth muscle within the dermis. Rarely, CSMH is associated with hemihypertrophy (Atzmony et al., 2020).

Professional guidelines

PubMed

Mighell TL, Evans-Dutson S, O'Roak BJ
Am J Hum Genet 2018 May 3;102(5):943-955. Epub 2018 Apr 26 doi: 10.1016/j.ajhg.2018.03.018. PMID: 29706350Free PMC Article
Pilarski R, Burt R, Kohlman W, Pho L, Shannon KM, Swisher E
J Natl Cancer Inst 2013 Nov 6;105(21):1607-16. Epub 2013 Oct 17 doi: 10.1093/jnci/djt277. PMID: 24136893
Au KS, Williams AT, Roach ES, Batchelor L, Sparagana SP, Delgado MR, Wheless JW, Baumgartner JE, Roa BB, Wilson CM, Smith-Knuppel TK, Cheung MY, Whittemore VH, King TM, Northrup H
Genet Med 2007 Feb;9(2):88-100. doi: 10.1097/gim.0b013e31803068c7. PMID: 17304050

Recent clinical studies

Etiology

Tischkowitz M, Colas C, Pouwels S, Hoogerbrugge N; PHTS Guideline Development Group; European Reference Network GENTURIS
Eur J Hum Genet 2020 Oct;28(10):1387-1393. Epub 2020 Jun 12 doi: 10.1038/s41431-020-0651-7. PMID: 32533092Free PMC Article
Huang YW, Kuo YJ, Ho CY, Lan MY
Eur Arch Otorhinolaryngol 2018 Mar;275(3):743-749. Epub 2018 Jan 30 doi: 10.1007/s00405-018-4885-8. PMID: 29380040
Farooq A, Walker LJ, Bowling J, Audisio RA
Cancer Treat Rev 2010 Dec;36(8):577-83. Epub 2010 May 23 doi: 10.1016/j.ctrv.2010.04.002. PMID: 20580873
Gustafson S, Zbuk KM, Scacheri C, Eng C
Semin Oncol 2007 Oct;34(5):428-34. doi: 10.1053/j.seminoncol.2007.07.009. PMID: 17920899
Arita K, Kurisu K, Kiura Y, Iida K, Otsubo H
Neurol Med Chir (Tokyo) 2005 May;45(5):221-31. doi: 10.2176/nmc.45.221. PMID: 15914961

Diagnosis

Saunders TFC, Bruijnzeel H, Ahmed S, Paruleka M, McDermott AL
J Laryngol Otol 2022 Dec;136(12):1140-1147. Epub 2021 Aug 23 doi: 10.1017/S0022215121002267. PMID: 34420530
Dickerson T, Poche W, Meaux T
Skinmed 2021;19(1):69-71. Epub 2021 Feb 1 PMID: 33658120
Taghavi A, Mirfazaelian H, Shirian S, Aledavood A, Akhgar A
Br J Hosp Med (Lond) 2018 Jun 2;79(6):352-353. doi: 10.12968/hmed.2018.79.6.352. PMID: 29894252
Shafer DM, Di Pasquale LM
Atlas Oral Maxillofac Surg Clin North Am 2014 Sep;22(2):153-66. doi: 10.1016/j.cxom.2014.04.002. PMID: 25171996
Hanssen AM, Fryns JP
J Med Genet 1995 Feb;32(2):117-9. doi: 10.1136/jmg.32.2.117. PMID: 7760320Free PMC Article

Therapy

Mirandola L, Cantalupo G, d'Orsi G, Meletti S, Vaudano AE, Di Vito L, Vignoli A, Tassi L, Pelliccia V
Epilepsy Behav 2023 Mar;140:109025. Epub 2023 Feb 11 doi: 10.1016/j.yebeh.2022.109025. PMID: 36780776
Jankowski R, Nguyen DT, Gallet P, Rumeau C
Eur Ann Otorhinolaryngol Head Neck Dis 2018 Dec;135(6):437-441. Epub 2018 Jun 20 doi: 10.1016/j.anorl.2018.05.008. PMID: 29934261
Portocarrero LKL, Quental KN, Samorano LP, Oliveira ZNP, Rivitti-Machado MCDM
An Bras Dermatol 2018 Jun;93(3):323-331. doi: 10.1590/abd1806-4841.20186972. PMID: 29924239Free PMC Article
Batra P, Loyd A, Patel R, Walters R, Stein JA
Dermatol Online J 2010 Nov 15;16(11):3. PMID: 21163154
Kirk ME
Int J Gynaecol Obstet 1978-1979;16(6):473-8. doi: 10.1002/j.1879-3479.1979.tb00952.x. PMID: 39811

Prognosis

Yehia L, Keel E, Eng C
Annu Rev Med 2020 Jan 27;71:103-116. Epub 2019 Aug 21 doi: 10.1146/annurev-med-052218-125823. PMID: 31433956
Huang YW, Kuo YJ, Ho CY, Lan MY
Eur Arch Otorhinolaryngol 2018 Mar;275(3):743-749. Epub 2018 Jan 30 doi: 10.1007/s00405-018-4885-8. PMID: 29380040
Farooq A, Walker LJ, Bowling J, Audisio RA
Cancer Treat Rev 2010 Dec;36(8):577-83. Epub 2010 May 23 doi: 10.1016/j.ctrv.2010.04.002. PMID: 20580873
Arita K, Kurisu K, Kiura Y, Iida K, Otsubo H
Neurol Med Chir (Tokyo) 2005 May;45(5):221-31. doi: 10.2176/nmc.45.221. PMID: 15914961
Calderone DC, Glass LF, Seleznick M, Fenske NA
J Dermatol Surg Oncol 1994 Dec;20(12):837-8. doi: 10.1111/j.1524-4725.1994.tb03716.x. PMID: 7798419

Clinical prediction guides

Mighell TL, Evans-Dutson S, O'Roak BJ
Am J Hum Genet 2018 May 3;102(5):943-955. Epub 2018 Apr 26 doi: 10.1016/j.ajhg.2018.03.018. PMID: 29706350Free PMC Article
Tan MH, Mester J, Peterson C, Yang Y, Chen JL, Rybicki LA, Milas K, Pederson H, Remzi B, Orloff MS, Eng C
Am J Hum Genet 2011 Jan 7;88(1):42-56. Epub 2010 Dec 30 doi: 10.1016/j.ajhg.2010.11.013. PMID: 21194675Free PMC Article
Gammon A, Jasperson K, Kohlmann W, Burt RW
Best Pract Res Clin Gastroenterol 2009;23(2):219-31. doi: 10.1016/j.bpg.2009.02.007. PMID: 19414148Free PMC Article
Arita K, Kurisu K, Kiura Y, Iida K, Otsubo H
Neurol Med Chir (Tokyo) 2005 May;45(5):221-31. doi: 10.2176/nmc.45.221. PMID: 15914961
Colaco P
Indian J Pediatr 1997 Mar-Apr;64(2):165-75. doi: 10.1007/BF02752439. PMID: 10771833

Recent systematic reviews

Rizzi M, Nichelatti M, Ferri L, Consales A, De Benedictis A, Cossu M; Commission for Epilepsy Surgery of the Italian League Against Epilepsy (LICE)
Epilepsy Res 2023 Dec;198:107261. Epub 2023 Nov 20 doi: 10.1016/j.eplepsyres.2023.107261. PMID: 38006630
Techasatian W, Gozun M, Morihara C, Pham A, Benavente K, Nagamine T, Nishimura Y
Cardiovasc Pathol 2023 Jul-Aug;65:107538. Epub 2023 Apr 7 doi: 10.1016/j.carpath.2023.107538. PMID: 37031829
Stanich PP, Pilarski R, Rock J, Frankel WL, El-Dika S, Meyer MM
World J Gastroenterol 2014 Feb 21;20(7):1833-8. doi: 10.3748/wjg.v20.i7.1833. PMID: 24587660Free PMC Article
Pilarski R, Burt R, Kohlman W, Pho L, Shannon KM, Swisher E
J Natl Cancer Inst 2013 Nov 6;105(21):1607-16. Epub 2013 Oct 17 doi: 10.1093/jnci/djt277. PMID: 24136893
MacDonald-Jankowski D
Dentomaxillofac Radiol 2009 May;38(4):196-215. doi: 10.1259/dmfr/16645318. PMID: 19372108

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...